Literature DB >> 10075395

The role of dietary calcium in hypertension: a hierarchical overview.

L M Resnick1.   

Abstract

The role of calcium in clinical hypertension can be best understood by a hierarchical model in which the blood pressure effects of a dietary signal depend on alterations of hormonal systems specific for that signal. These alterations mediate both the cellular recognition of these signals as well as the resultant clinical responses to them. In the case of both dietary calcium and dietary salt, these systems appear to include calcium regulating hormones having direct, calcium-dependent vasoactive properties, and which are linked to the activity of the renin-angiotensin system. Altered salt and calcium intake exert reciprocal linked effects on these hormone systems and on blood pressure. These reflect altered cellular calcium uptake from the extracellular space, salt-induced calcium hormones stimulating and calcium-induced suppression of these hormones inhibiting extracellular calcium uptake. Among normotensive individuals, this is associated with a reciprocal calcium-dependent suppression or stimulation of renin secretion, respectively, resulting in an offsetting decreased or increased angiotensin II-mediated release of calcium into the cytoplasm from intracellular stores. Hence, no significant change in cytosolic free calcium or, consequently, in blood pressure usually results from increasing or decreasing dietary salt or calcium intake. However, whether due to genetic or other environmental factors as yet undefined, the metabolic "set point" of plasma renin activity in some subjects is already suppressed, or, alternatively, is unresponsive to the above hormonally mediated dietary mineral variations. Under these circumstances, increases in dietary salt will cause cytosolic free calcium and thus blood pressure to rise, whereas increased dietary calcium in these very same "salt-sensitive" subjects will offset the effect of salt, and lower pressure in these individuals. This analysis suggests that although increasing oral calcium intake to achieve at least current nutritional standards is entirely appropriate, uniform recommendations for all hypertensives to further increase or decrease dietary calcium or salt may be inappropriate and will obscure those for whom these maneuvers are particularly relevant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075395     DOI: 10.1016/s0895-7061(98)00275-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  18 in total

Review 1.  The role of calcium in the prevention of cardiovascular disease--a review of observational studies and randomized clinical trials.

Authors:  Susanne Rautiainen; Lu Wang; JoAnn E Manson; Howard D Sesso
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 2.  Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials.

Authors:  Lu Wang; JoAnn E Manson; Howard D Sesso
Journal:  Am J Cardiovasc Drugs       Date:  2012-04-01       Impact factor: 3.571

3.  Low Calcium Intake in Midpregnancy Is Associated with Hypertension Development within 10 Years after Pregnancy: The Norwegian Mother and Child Cohort Study.

Authors:  Grace M Egeland; Svetlana Skurtveit; Solveig Sakshaug; Anne Kjersti Daltveit; Bjørn E Vikse; Margaretha Haugen
Journal:  J Nutr       Date:  2017-07-12       Impact factor: 4.798

Review 4.  Current Perspectives on Antihypertensive Probiotics.

Authors:  Eric Banan-Mwine Daliri; Byong H Lee; Deog H Oh
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

5.  Differential Effect of Renal Cortical and Medullary Interstitial Fluid Calcium on Blood Pressure Regulation in Salt-Sensitive Hypertension.

Authors:  Mildred A Pointer; Shaleka Eley; Lauren Anderson; Brittany Waters; Brittany Royall; Sheena Nichols; Candace Wells
Journal:  Am J Hypertens       Date:  2014-12-31       Impact factor: 2.689

6.  Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

Authors:  Karen L Margolis; Roberta M Ray; Linda Van Horn; Joann E Manson; Matthew A Allison; Henry R Black; Shirley A A Beresford; Stephanie A Connelly; J David Curb; Richard H Grimm; Theodore A Kotchen; Lewis H Kuller; Sylvia Wassertheil-Smoller; Cynthia A Thomson; James C Torner
Journal:  Hypertension       Date:  2008-09-29       Impact factor: 10.190

7.  Short-term nutritional counseling reduces body mass index, waist circumference, triceps skinfold and triglycerides in women with metabolic syndrome.

Authors:  Gustavo D Pimentel; Silvia T Arimura; Bruno M de Moura; Maria E R Silva; Maysa V de Sousa
Journal:  Diabetol Metab Syndr       Date:  2010-02-10       Impact factor: 3.320

8.  Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.

Authors:  M K Kim; S J Chon; E B Noe; Y H Roh; B H Yun; S Cho; Y S Choi; B S Lee; S K Seo
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

9.  Calcium Supplements and Cardiovascular Disease: A Review.

Authors:  Talya Waldman; Raheleh Sarbaziha; C Noel Bairey Merz; Chrisandra Shufelt
Journal:  Am J Lifestyle Med       Date:  2015-07-01

10.  Borderline high serum calcium levels are associated with arterial stiffness and 10-year cardiovascular disease risk determined by Framingham risk score.

Authors:  Byoungjin Park; Yong-Jae Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.